Platelets Possess and Require an Active Protein Palmitoylation Pathway for Agonist-Mediated Activation and In Vivo Thrombus Formation
Authors:
- 1 June 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 27 (6) , 1478-1485
Abstract
Objective— Several platelet proteins are palmitoylated, but whether protein palmitoylation functions in platelet activation is unknown. We sought to determine the role of platelet protein palmitoylation in platelet activation and thrombus formation. Methods and Results— Platelet proteins were depalmitoylated by infusing acyl-protein thioesterase 1 into permeabilized platelets. In intact platelets, platelet protein palmitoylation was blocked using the protein palmitoylation inhibitor cerulein. The effects of inhibiting platelet protein palmitoylation on platelet function and on thrombus formation in vivo were evaluated. When infused into permeabilized platelets, acyl-protein thioesterase 1 reduced total platelet protein palmitoylation and inhibited protease-activated receptor-1–mediated α-granule secretion with an IC 50 of 175 nmol/L and maximal inhibition of ≥90%. G αq and SNAP-23, membrane-associated proteins that are constitutively palmitoylated, translocated to the cytosol when permeabilized platelets were exposed to recombinant acyl-protein thioesterase 1. The protein palmitoylation inhibitor cerulein also inhibited platelet granule secretion and aggregation. Studies using intravital microscopy showed that incubation with cerulein decreased the rate of platelet accumulation into thrombi formed after laser-induced injury of mouse arterioles and inhibited maximal platelet accumulation by >60%. Conclusion— These studies show that platelets possess a protein palmitoylation machinery that is required for both platelet activation and platelet accumulation into thrombi. These studies show that inhibition of platelet protein palmitoylation blocks platelet aggregation and granule secretion. In a murine model of thrombus formation, inhibition of protein palmitoylation markedly inhibits platelet accumulation into thrombi at sites of vascular injury.Keywords
This publication has 39 references indexed in Scilit:
- Differential requirements for calcium and Src family kinases in platelet GPIIb/IIIa activation and thromboxane generation downstream of different G-protein pathwaysBlood, 2005
- Huntingtin interacting protein 14 is an oncogenic human protein: palmitoyl acyltransferaseOncogene, 2004
- Molecular Basis of Platelet Granule SecretionArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Protein kinase C Mediates Translocation of Type II Phosphatidylinositol 5-Phosphate 4-Kinase Required for Platelet α-Granule SecretionJournal of Biological Chemistry, 2003
- Localization of the Adhesion Receptor Glycoprotein Ib-IX-V Complex to Lipid Rafts Is Required for Platelet Adhesion and ActivationJournal of Experimental Medicine, 2002
- Structure−Activity Studies of Cerulenin Analogues as Protein Palmitoylation InhibitorsJournal of Medicinal Chemistry, 1999
- SNAP-23 and SNAP-25 Are Palmitoylatedin VivoBiochemical and Biophysical Research Communications, 1999
- A Cytoplasmic Acyl-Protein Thioesterase That Removes Palmitate from G Protein α Subunits and p21RASJournal of Biological Chemistry, 1998
- Acylation of adenylyl cyclase catalyst is important for enzymic activityFEBS Letters, 1995
- Agonist-enhanced palmitoylation of platelet proteinsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1989